Hjem
John Alexander Cairnss bilde

John Alexander Cairns

Professor, II
  • E-postJohn.Cairns@uib.no
  • Besøksadresse
    Fosswinckelsgate 14
  • Postadresse
    Postboks 7802
    5020 BERGEN
Vitenskapelig artikkel
  • Vis forfatter(e) (2021). Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway. Quality of Life Research. 1-12.
  • Vis forfatter(e) (2021). How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review. BMC Cancer. 21 sider.
  • Vis forfatter(e) (2020). HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective? . PharmacoEconomics - Open. 529-539.
  • Vis forfatter(e) (2020). Disagreement on cancer drug decisions in Europe. International Journal of Technology Assessment in Health Care. 232-238.
  • Vis forfatter(e) (2019). What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries. Health Policy. 130-139.
  • Vis forfatter(e) (2018). The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluation. European Journal of Cancer. 89-98.
  • Vis forfatter(e) (2018). Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer. PLOS ONE. 1-23.
  • Vis forfatter(e) (2017). Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia. European Journal of Health Economics. 1-13.
  • Vis forfatter(e) (2017). Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst Scaling. Value in Health. 799-808.
  • Vis forfatter(e) (2015). Why do some countries approve a cancer drug and others don’t? Journal of Cancer Policy. 21-25.
  • Vis forfatter(e) (2010). Think twice before you book? Modelling the choice of public vs private dentist in a choice experiment. Health Economics. 670-682.
  • Vis forfatter(e) (2007). Time preferences for health in northern Tanzania - An empirical analysis of alternative discounting models. PharmacoEconomics (Auckland). 73-88.
  • Vis forfatter(e) (2006). Preferences over dental restorative materials among young patients and dental professionals. European Journal of Oral Sciences. 15-21.
  • Vis forfatter(e) (2004). Repeated follow-up as a method for reducing non-trading behaviour in discrete choice experiments. Social Science and Medicine. 2211-2218.
Rapport
  • Vis forfatter(e) (2004). Elicting Patient and Professional Preferences for Dental Restorations. .
Vitenskapelig foredrag
  • Vis forfatter(e) (2004). Eliciting patient and professional preferences for dental restorations.
  • Vis forfatter(e) (2004). Eliciting patient and professional preferences for dental restorations.
Vitenskapelig antologi/Konferanseserie
  • Vis forfatter(e) (2017). Cancer Biomarkers: Ethics, Economics and Society. Megaloceros Press.
Sammendrag/abstract
  • Vis forfatter(e) (2004). Preferences by dental professionals and teenage patients related to attributes of restorative materials. European Journal of Paediatric Dentistry.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2017). A systematic literature review of health state utility values in head and neck cancer. Health and Quality of Life Outcomes. 1-13.

Se fullstendig oversikt over publikasjoner i CRIStin.